Spring Wind

Beijing Chunfeng Pharmaceutical (often referred to as Spring Wind Pharmaceutical) is a modern pharmaceutical enterprise based in Beijing, China, that specializes in the research, development, and production of Traditional Chinese Medicine (TCM) and chemical drugs. The company is a leader in the modernization of TCM, particularly through its production of formula granules and its development of treatments for respiratory and cardiovascular diseases. Chunfeng Pharmaceutical gained significant recognition for its Jinhua Qinggan Granules, which were widely utilized in the clinical management of COVID-19 and influenza. Operating as a national high-tech enterprise, the company maintains large-scale GMP-certified manufacturing facilities and focuses on integrating traditional herbal wisdom with contemporary pharmaceutical standards and rigorous quality control.